Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689870010 | Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689872019 | Palivizumab 100 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Palivizumab only product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antiviral therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | médicament contenant palivizumab (produit médicinal) | false | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | a une forme pharmaceutique (attribut) | Powder for solution for injection | true | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value (attribute) | 100 | false | Inferred relationship | Some | 1 | |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Respiratory syncytial virus monoclonal antibody | true | Inferred relationship | Some | 1 | |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Respiratory syncytial virus monoclonal antibody | true | Inferred relationship | Some | 1 | |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug) | est un(e) (attribut) | True | Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR